metformin has been researched along with Leukemia, T-Cell in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin was also included as a positive control for the anti-proliferative and pro-apoptotic effects." | 1.48 | Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells. ( Gao, H; Hong, T; Wang, H; Wei, R; Yang, J; Yu, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, R | 1 |
| Yu, F | 1 |
| Yang, J | 1 |
| Gao, H | 1 |
| Wang, H | 1 |
| Hong, T | 1 |
1 other study available for metformin and Leukemia, T-Cell
| Article | Year |
|---|---|
Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Humans; Jurkat Cells; | 2018 |